New York, NY (TopGun Press)
Sanofi announced earlier this quarter that François-Xavier Roger will be appointed Chief Financial Officer and a member of Sanofi’s Executive Committee effective April 1, 2024. François-Xavier will join most recently from Nestle, where he had been CFO since July 2015. Prior to Nestle, Mr. Roger held senior finance roles in the Pharma space at Takeda Pharmaceutical and several predecessor companies of what is today, Sanofi. When Nestle announced in 2Q 2023 that François-Xavier Roger had decided to step down, investors rated him a Top 10 CFO out of over 100 Global Consumer Products companies tracked on BWI’s Investor Confidence Index.
Given this CFO transition, we’re providing the historical Half Year Commitment to Own Nestle Trends and Shareholder Conviction Trends on Nestle’s CFO, Transparency & Disclosure and Balance Sheet during Mr. Roger’s tenure as CFO at Nestle, along with the relevant investor verbatim commentary.
Typical Verbatim Commentary on Nestle’s CFO:
(July 1st, 2015 through June 30th, 2023)
“Nestle’s CFO, François-Xavier Roger, has done a great job.”
“Nestle’s CFO is phenomenal.”
“Nestle’s CFO is gaining ground.”
“The Nestle CFO is improving.”
“François-Xavier Roger, Nestle’s CFO is very good. He would be a TopGun.”
“I know the Nestle CFO well. He is pretty solid and has been doing a very good job there.”
“The CFO is great and has improved the disclosure and visibility for the company.”
“I think Nestle’s CFO is a straightforward guy, addresses the business’ issues and is very clear in the statements he makes.”
“I meet with Nestle’s CFO three or four times a year and he really knows the company well. He’s a very active CFO and not just in accounting.”
“Nestle’s CFO does an excellent job communicating with the investment community.”
“Nestle’s CFO, François-Xavier Roger, thinks like investors.”
“The CFO at Nestle gets a bit of a halo effect because of the CEO.”
“Nestle’s CFO is not really the one calling the shots.”
“Nestle’s CFO could be more specific on calls sometimes.”
If you would like to subscribe to the BWI Shareholder Confidence Intel including full reports on individual companies with verbatim please send an email to aknott@brendanwood.com or jnovak@brendanwood.com
Click Here for the Brendan Wood International Investor Conviction Intel – Healthcare – AbbVie CEO Succession
Click Here for the Brendan Wood International Investor Conviction Intel – Healthcare – January 2024
Click Here for the Brendan Wood International Investor Conviction Intel – Healthcare – November 2023
Brendan Wood International (BWI) serves a dual clientele of world leading investors and their corporate investment targets as well as broker dealers who provide research, sales and trading services to the investment community. Big cap companies looking for comprehensive investor confidence data on their organizations are likely to discover that Brendan Wood partners consult with their investors non stop year round. Investors depend on BWI to quantify the demand side of the investment industry across 1400 names worldwide, including the name by name research sales and trading professionals who influence investor demand.
About Brendan Wood International:
Brendan Wood International (BWI), formed in 1970, is a private advisory group which originates performance investigation programs in the capital markets. Brendan Wood Partners debrief large institutional investors worldwide on a daily basis. There are 2000+ live consultations with professionals overseeing +/- $55 trillion invested in the +/- 1400 big cap companies on the BWI Index. Relying on its real time performance intelligence, BWI advises public companies, institutional and activist investors, investment banks and broker dealers on strategy, performance and recruitment of TopGun talent. The firm’s partners have formally presented at 1000+ C level strategy meetings and corporate off-sites in fifty cities. Brendan Wood founded the exclusive TopGun Club, a performance based institution.
Disclaimer:
We wish to emphasize that all reports, evaluations and assessments contained herein, represent Brendan Wood International’s subjective judgment and opinions, based on our years of experience and on information obtained by us in the course of our research. Much of the factual information contained in the reports has been obtained by us from third parties on whose responses we have relied in good faith, independent verification by Brendan Wood International being, under the circumstances, impossible. While we believe that you will find our reports to be an invaluable tool in formulating your own strategies and judgments, the foregoing should be borne in mind. This report is not meant as investment advice and should not be interpreted as advising on the value of a company’s securities, the advisability of investing in, purchasing or selling any company’s securities or any other conclusion relating to investment/divestiture of a company’s securities. Finally, this report is not intended as an offer or solicitation for the purchase or sale of any company’s securities.
www.TopGunPress.com
www.brendanwood.com
@BrendanWoodIntl
Contacts:
Amanda Knott
Managing Director
Brendan Wood International
+1 416 924 8110
aknott@brendanwood.com
Jordan Novak
Partner
Brendan Wood International
+1 416 924 8110
jnovak@brendanwood.com
Posted in Press Releases
|
You can follow any responses to this entry through the RSS 2.0 feed.
Both comments and pings are currently closed.
